MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

New York policy

A7409: Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists

NY Assembly · Sponsor Keith Brown

Jurisdiction
New York State
Applies to
New York State (proposed)
Effective
January 7, 2026

What it requires

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.

ny-stateassemblylegislationbill

Official source ↗

Free account

Create a free account

Track New York policy and save searches across the Network. Free. No card required.

or email

Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →